How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

HO

NASDAQ:HOLX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

HO

Hologic IncNASDAQ HOLX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is HOLX undervalued compared to its fair value?

The fair value of HOLX stock is hidden USD. Relative to the market price of 77.66 USD Hologic Inc is hidden.

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in ...[More about valuation]

Hologic Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

18.311 $B

Price:

77.66 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.715

HOLX stock is better priced for investment 20% of the companies in Healthсare sector
HOLX stock is better priced for investment 19% of the companies on Nasdaq Exchange

FINANCIALS

Hologic financial for reporting period

Income Statement

1 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.17 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

1 B 100%
0.57 B 56%
0.17 B 17%

Balance Sheet

8.7 B
4.8 B

Financial Position Analysis

Assets

8.7 B
Current Assets
3.8 B
Total non-current assets
4.9 B

Total current liabilities
0.95 B
Total non-current liabilities
2.9 B

Cash Flow Statement

0.25 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.29 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Hologic fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

9 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-3 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
5 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is HOLX attractive for investment based on fundamental analysis?

HOLX stock rating is hidden. Hologic is a hidden by Eyestock methodology.

Get HOLX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

12

Gross Margin:

55

CFO / Debt ratio:

hidden

Current ratio:

3.911

Debt / Equity ratio:

0.549

ROE:

9

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

HOLX analysis by AI

Was this information helpful?

Eyebot AI analysis

Hologic Inc, a health-care sector company, has shown a mixed performance in its latest financial reports. One of the strengths of the company is its high gross margin, indicating efficiency in managing production costs. Additionally, the current ratio and equity ratio have been consistently above industry benchmarks, reflecting strong liquidity and a healthy balance sheet. However, there are some concerning factors as well. The return on equity (ROE) and return on invested capital (ROIC) have been below the industry standards, suggesting that the company may not be effectively utilizing its capital resources. The stability ratios over the past few quarters have shown a decline, indicating potential risks in the company's operations. Furthermore, the company's net profit margin has been fluctuating, and the cash flow from operations to net income ratio has been inconsistent. These factors may raise red flags about the company's financial stability and earnings quality. Overall, while Hologic Inc demonstrates certain strengths in its financial performance, the inconsistent profitability and declining stability ratios pose risks for potential investors. Further analysis is recommended to assess the company's investment potential.

Hologic Inc competitors

AB

ABT

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Par...

Discover

IS

ISRG

Intuitive Surgical Inc

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company i...

Discover

SY

SYK

Stryker Corp

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. The company is ...

Discover

Hologic Inc dividends

HOLX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About HOLX stock

About the company Hologic Inc

Market cap $B

18.311

Dividend yield

Shares outstanding

246.554 B

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,944 full-time employees. The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics segment offers a range of diagnostics products, such as ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Its Breast Health segment offers a portfolio of solutions for breast cancer care, primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment offers a range of products, such as NovaSure Endometrial Ablation System, MyoSure Hysteroscopic Tissue Removal System and Fluent Fluid Management system as well as its Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, and the Fluoroscan Insight FD mini C-arm.

HOLX profile

  • Ticker

    HOLX

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    01 March 1990

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

    6944

  • City

    Marlborough

  • Address

    250 Campus Drive

  • Cusip

    436440101